The Neuroscience pharmaceuticals market is expected to double in size in the next ten years. An expanding elderly population means that the prevalence of neurodegenerative diseases is increasing every year and represents a significant global health burden.

Neurodegenerative diseases such as Alzheimer’s disease and other dementias, Parkinson’s disease and amyotrophic lateral sclerosis (ALS or motor neurone disease) are estimated to affect nearly seven million people collectively in the US alone. Yet disease-modifying therapies are still currently beyond the reach of patients, with prevention so far completely unattainable.

The eBook explores the latest innovations in neuroscience drug discovery and how new approaches could revolutionise their treatment.

Download now to read articles on:

• A new generation of therapies for neurodegenerative conditions
• The promise of a botanical approach to autism
• How active immunotherapies could lead to better treatment of Alzheimer’s
• The validity of the amyloid hypothesis in light of the Cochrane review

Sponsored by